JSF Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.69M Buy
2,239
+1,252
+127% +$1.28M 0.42% 33
2026
Q1
$908K Sell
987
-102
-9% -$103K 0.18% 76
2025
Q4
$1.17M Sell
1,089
-4
-0.4% -$3.83K 0.24% 57
2025
Q3
$834K Sell
1,093
-23
-2% -$17.1K 0.19% 75
2025
Q2
$870K Buy
1,116
+125
+13% +$97.1K 0.21% 72
2025
Q1
$819K Buy
991
+5
+0.5% +$4.16K 0.22% 72
2024
Q4
$761K Sell
986
-1,045
-51% -$865K 0.2% 73
2024
Q3
$1.8M Sell
2,031
-8
-0.4% -$7.19K 0.52% 34
2024
Q2
$1.85M Buy
2,039
+50
+3% +$40K 0.57% 31
2024
Q1
$1.55M Buy
1,989
+1,067
+116% +$759K 0.48% 32
2023
Q4
$538K Sell
922
-83
-8% -$48.4K 0.19% 66
2023
Q3
$540K Sell
1,005
-92
-8% -$47.4K 0.21% 59
2023
Q2
$514K Buy
1,097
+95
+9% +$39.8K 0.18% 63
2023
Q1
$344K Sell
1,002
-62
-6% -$20.9K 0.13% 88
2022
Q4
$389K Sell
1,064
-201
-16% -$71.3K 0.15% 84
2022
Q3
$409K Sell
1,265
-1,781
-58% -$564K 0.16% 79
2022
Q2
$988K Sell
3,046
-9
-0.3% -$2.7K 0.45% 36
2022
Q1
$875K Buy
3,055
+189
+7% +$48.6K 0.37% 39
2021
Q4
$792K Buy
2,866
+4
+0.1% +$1.01K 0.39% 35
2021
Q3
$661K Buy
2,862
+254
+10% +$62.7K 0.33% 38
2021
Q2
$599K Buy
2,608
+157
+6% +$31.5K 0.35% 35
2021
Q1
$458K Sell
2,451
-350
-12% -$68.5K 0.29% 43
2020
Q4
$473K Buy
2,801
+378
+16% +$56.4K 0.33% 36
2020
Q3
$359K Buy
2,423
+354
+17% +$54.8K 0.28% 43
2020
Q2
$340K Buy
2,069
+234
+13% +$35.9K 0.29% 43
2020
Q1
$255K Buy
+1,835
New +$252K 0.26% 49

Other funds holding LLY

JSF Financial's LLY Position: Q2 2026 in Review

JSF Financial increased its Eli Lilly (LLY) stake by 127% in Q2 2026, buying an estimated $1.28M and bringing the position to 2,239 shares worth $2.69M. The position accounts for 0.42% of the portfolio, ranked #33.

JSF Financial first reported a position in LLY in Q1 2020 and has held it in 26 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • JSF Financial held 2,239 shares of Eli Lilly worth $2.69M as of Q2 2026.
  • JSF Financial bought 1,252 Eli Lilly shares in Q2 2026, an estimated $1.28M.
  • Eli Lilly made up 0.42% of JSF Financial's portfolio in Q2 2026, its #33 holding.
  • JSF Financial first reported a position in Eli Lilly in Q1 2020 and has held it in 26 quarters since.
  • 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on JSF Financial's 13F filing for Q2 2026, filed 28 Jul 2026.